BrainEver logo

BrainEver jobs and careers

Saint-antoine, France

About BrainEver

BrainEver’s innovative therapeutic strategy is a translation of the work by Alain Prochiantz and colleagues on brain development and physiology. They demonstrated that homeoproteins, first identified as early developmental regulators, are also active throughout life and control several neuronal functions, including metabolism and epigeneticstability.BrainEver makes the hypothesis that, in patients, homeoprotein administration could durably modify the physiological resistance of surviving neurons while increasing their activity, thus leading to the improvement of clinical symptoms.Different homeoproteins that could be important in different neurodegenerative pathologies are being explored, the most advanced being Engrailed 1 (BREN01) for the treatment of Parkinson Disease and Amyotrophic Lateral Sclerosis (ALS).Beside Engrailed 1 in Parkinson Disease and ALS, BrainEver is currently generating a pipeline of 4 drug candidates targeting other neurodegenerative disease like Huntington Disease and Optic Neuropathies.

Employees
11 to 50
Headquarters
Saint-antoine

Leadership

The top of BrainEver's org chart, with how many people report into each leader.

BGPhoto of Bernard Gilly

Bernard Gilly

CEO

8 reports

APPhoto of Alain Prochiantz

Alain Prochiantz

Co-founder & Chief Scientific Officer

2 reports

ABPhoto of Anne Bousseau

Anne Bousseau

Chief Medical Officer

1 report

CP

Catherine Pletan

Acting Chief Operating Officer / Head of Operations

HMPhoto of Hubert Mechain

Hubert Mechain

CTO - Chief Technical Officer

CFPhoto of Claire Friedel

Claire Friedel

Business Development